Drug Database
Back to search

Switzerland· 58314004

Privigen, Infusionslösung

A humane immunglobuline, unspezifisch, intravaskulär product containing immunoglobulinum humanum normale, registered in Switzerland by CSL Behring AG and dispensed under Swissmedic category B, on the national reimbursement list. The same ATC class is registered in 11 of our 19 countries.

Reimbursed in Switzerland (BAG SL)Cat B (Swissmedic)ATC J06BA02

Checked against Swissmedic (Switzerland) on

Informational only — not a medical device.

SOURCE REGISTER · CHSwissmedic (Switzerland)normalisedPrivigen, InfusionslösungATCJ06BA02REGISTER NO.58314004PACKS LISTED1CHECKEDSeptember 12, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about immunoglobulinum humanum normaleAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Humane immunglobuline, unspezifisch, intravaskulär is registered in 11 of 19 countries.

Countries holding a registration under ATC J06BA02 (humane immunglobuline, unspezifisch, intravaskulär), each read from that country’s own register.

  • This record: Switzerland, from Swissmedic (Switzerland)
  • 7 of them publish a price we can compare per daily dose
Search humane immunglobuline, unspezifisch, intravaskulär products by name

Humane immunglobuline, unspezifisch, intravaskulär · ATC J06BA02

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Swissmedic (Switzerland)
Active substance
immunoglobulinum humanum normale
Manufacturer
CSL Behring AG
Country
Switzerland (CH)
ATC code
J06BA02
ATC class
Humane Immunglobuline, unspezifisch, intravaskulär
Defined daily dose
1.6 g, P
Swissmedic category
B
Reimbursed
Yes
Source register
Swissmedic (Switzerland)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • gtin
    7680583140046
    Durchstf 200 ml
    CHF 1470.6

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

48 interactions on record for humane immunglobuline, unspezifisch, intravaskulär.

Graded by severity as the source publishes them — 44 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check humane immunglobuline, unspezifisch, intravaskulär against other medicinesHow interaction checks work

Humane immunglobuline, unspezifisch, intravaskulär · interactions on record

48 records

  • 44 severe
  • 4 minor

Most severe, free to view

  • NeomycinA07AA01severe
  • StreptomycinA07AA04severe
  • Polymyxin BA07AA05severe
  • Amphotericin BA07AA07severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same class

Other records under J06BA02

Humane immunglobuline, unspezifisch, intravaskulär, as other registers publish it.

All humane immunglobuline, unspezifisch, intravaskulär products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b7d2bad0-34ab-4f90-ac92-969c4c3e87be
GET /v1/drugs/b7d2bad0-34ab-4f90-ac92-969c4c3e87be?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "unit": null,
  "strength": "immunoglobulinum humanum normale 20 g",
  "valid_from": "2008-12-01",
  "limitations": "[{\"description\":\"Nur bei Antikörpermangelsyndrom, idiopathischer thrombozytopenischer Purpura, Guillain-Barré-Syndrom, Kawasaki-Syndrom und chronisch inflammatorischer demyelisierender Polyneuropathie (CIDP) und multifokaler motorischer Neuropathie (MMN).<br>\\n<br>\",\"costApproval\":null,\"isNew\":false,\"limitationCode\":null,\"priceModel\":null,\"validFrom\":\"2020-04-01\"}]",
  "galenic_form": "Inf Lös 20 g/200ml i.v.",
  "therapeutic_area": null,
  "sl_inclusion_date": "2008-12-01",
  "self_retention_pct": 10
}
API referenceMCP serverPlans

See everything about humane immunglobuline, unspezifisch, intravaskulär.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console